Skip to main content
. Author manuscript; available in PMC: 2012 Sep 17.
Published in final edited form as: J Matern Fetal Neonatal Med. 2011 Jun 1;25(4):379–384. doi: 10.3109/14767058.2011.580402

Table V.

Subgroup analysis stratified by primary language (English and Spanish/Other): Multivariable logistic regression analysis* of maternal and neonatal outcomes associated with oral hypoglycemic agents compared to subcutaneous insulin

Spanish/Other
(n = 4,335)
English
(n = 5,273)


aOR 95% CI aOR 95% CI
Maternal Outcome
  Cesarean delivery
    Overall cesarean 0.78 0.63–0.94 0.82 0.68–0.98
    Primary cesarean 0.95 0.73–1.24 0.90 0.73–1.11
Neonatal Outcome
  Preterm delivery
    <37 weeks 1.12 0.83–1.53 0.99 0.75–1.31
    <34 weeks 2.04 1.18–3.54 1.11 0.56–2.17
  Birthweight
    >4,000gm 1.09 0.83–1.44 1.09 0.83–1.43
    >4,500gm 1.07 0.65–1.76 1.12 0.68–1.83
  Birth weight >90th centile 1.40 1.02–1.94 1.00 0.79–1.27
  Intrauterine fetal demise 0.94 0.17–4.95 5.31 1.06–26.5
  Neonatal intensive care unit admission 2.54 1.55–4.13 0.86 0.48–1.56

Reference comparison group: women treated with subcutaneous insulin injections.

*

Multivariable logistic regression controlling for potential confounding covariates, including maternal age, parity, ethnicity, gestational age at GDM diagnosis, gestational weight gain, education level, and prepregnancy BMI.

In term pregnancies (gestational age at delivery >37 weeks) only.